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1. Introduction 
Millions of people experience consequential tooth loss related to irretrievable damage of the 
periodontium caused by deep caries, severe periodontal diseases or irreversible trauma, 
resulting in a decreased quality of life. Hence, dental scientists have focused much attention 
on tissue engineering techniques in an effort to address this condition. The periodontium is 
composed mainly of two soft tissues and two hard tissues; the former includes the 
periodontal ligament (PDL) tissue and gingival tissue, and the latter includes alveolar bone 
and cementum covering the tooth root. In particular, PDL is a dynamic connective tissue 
that is subjected to continual adaptation to maintain tissue size and width, as well as 
structural integrity, including fibers and bone modeling. The main role of PDL is to anchor 
the tooth root to the alveolar bone socket tightly, cushioning mechanical load that proceeds 
from mastication. Thus, PDL tissue constitutes the bedrock of periodontium to determine 
the life-span of tooth. In this chapter, we describe the phenotypes of multipotent clonal 
human PDL progenitor/stem cell lines that we have recently established, and present a 
comparison with PDL stem cells (PDLSCs). 
PDLSCs represent typical properties of bone marrow-derived mesenchymal stem cells 
(BMMSCs). PDLSCs exhibit a self-renewing capacity and express cell surface markers similar 
to BMMSCs. PDLSCs also possess the multipotential to differentiate into various types of cells, 
such as osteoblast-like cells, adipocytes, chondrocytes and neurocytes, in vitro. Additionally, 
PDLSCs represent a distinctive potential to form cementum- and PDL-like tissues in vivo, 
suggesting that PDLSCs might belong to a unique population of somatic stem cells. 
Since a very small number of stem cells are included in PDL tissue, researchers have tried to 
establish immortalized PDL stem cell lines for the convenience and consistency of analyses. 
Recently, we succeeded in establishing two clonal human PDL cell lines with multipotential 
by transduction with Simian Virus (SV) 40 large T-antigen and human telomerase reverse 
transcriptase. These clonal cell lines exhibited unique characteristics: cell line 1-11 
demonstrated osteoblastic and adipocytic differentiation capabilities, and cell line 1-17 
exhibited the potential to differentiate into osteoblasts, adipocytes, chondrocytes and 
neurocytes. Flow cytometric analysis demonstrated that the percentage of cells expressing 
BMMSC markers was very high in both cell lines. On the other hand, cell line 1-17 expressed 
embryonic stem (ES) cell marker genes at higher levels, compared with cell line 1-11. 
Furthermore, both cell lines expressed PDL phenotype-related molecules at equivalent 
levels while BMMSCs showed little expression. When transplanted into PDL defects formed 
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in immunodeficient rats, cell line 1-11 homed on the surface of bone and cementum, and 
between bone and cementum, while cell line 1-17 was localized only between bone and 
cementum. Thus, we believe that both cell lines met the prerequisite for PDL stem cells, and 
furthermore, that the differentiation stage of cell line 1-17 may be more immature than that 
of cell line 1-11. 
Differential analyses between these two clones will allow us to further reveal the mechanism 
of differentiation of PDL stem cells, as well as to elucidate key signals to direct stem cells, 
including other MSCs, induced pluripotent stem (iPS) cells or ES cells, toward the PDL-
lineage. 
2. What is the origin of PDL? 
PDL tissue originates from cranial neural crest (CNC)-derived ectomesenchymal cells (Chai 
et al., 2000). Neural crest cells are multipotent cell populations derived from the dorsal 
surface of the neural tube and migrate extensively during early stages of embryogenesis 
(Bronner-Fraser, 1993). The neural crest is divided into four specific regions that include the 
CNC, trunk neural crest, vagal and sacral neural crest, and cardiac neural crest, depending 
on the crest cell potentials to develop into particular tissues. During craniofacial 
development, CNC cells migrate ventrolaterally and contribute significantly to the 
formation of mesenchymal structures in the head and neck (Le et al., 1993). When tooth 
development begins, the primitive oral epithelium thickens and proliferates into the 
underlying CNC-derived ectomesenchyme, promoting mesenchymal cellular condensation. 
The dental follicle (DF) derived from CNC (Chai et al., 2000) is a sac including these 
structures, namely the odontogenic organ during tooth germ development (Cho et al., 2000). 
DF cells differentiate into PDL cells and are also believed to contain the progenitor cells that 
differentiate into cementoblasts and osteoblasts (Ten Cate, 2008). Thus, the DF plays a 
crucial role in forming the PDL tissue, namely the fabrication of the periodontium. 
3. What are PDL tissues and what are their roles? 
PDL tissue is a major constituent of the periodontium, along with other components, such as 
gingival soft tissue, the cementum covering the tooth root and alveolar bone (Melcher, 
1984). PDL tissue is a dynamic soft connective tissue that is situated between the tooth root 
and the bone socket, and the width of PDL tissue ranges from 0.15 to 0.38 μm (Ten Cate, 
2008). PDL tissue is composed of heterogeneous cell populations, various fibers, non-
collagenous extracellular matrix (ECM) proteins, nerve fibers and blood vessels. PDL cell 
populations include fibroblasts, which are principal cells in PDL tissue (Berkovitz et al., 
1995; Beertsen et al., 1997), undifferentiated mesenchymal cells, epithelial cell rests of 
Malassez and endothelial cells. 
PDL cells not only produce collagen fibers and other ECM proteins, but have 
osteoblastic/cementoblastic properties (Roberts et al., 1982; McCulloch et al., 1991), such as 
high alkaline phosphatase (ALP) activity (Lekic et al., 1996) and the expression of osteoblast-
related genes, including Runt-related transcription factor-2 (Fujii et al., 2006), Osterix (Kato 
et al., 2005), bone sialoprotein (Lekic et al., 2001), osteopontin (Chutivongse et al., 2005), 
osteocalcin (Li et al., 2001) and periostin (Yamada et al., 2001). Additionally, PDL cells 
synthesize an osteoclastogenesis activator, receptor activator of NF-kappa B ligand (Kanzaki 
et al., 2001), as well as its inhibitor, osteoprotegerin (Wada et al., 2001; Hasegawa et al., 
2002), suggesting that these cells participate in alveolar bone metabolism. 
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The fibers in PDL tissues mainly comprise collagens and elastic system fibers. The 
predominant collagen in PDL tissue is type I collagen, and other collagens (types III, VI and 
XII) are also deposited in PDL tissue (Lukinmaa et al., 1992; MacNeil et al., 1998). The collagen 
fibers in PDL tissue form in definite and distinct bundles; the terminus of the principal 
collagen bundles insert into the cementum and alveolar bone, as known as Sharpey’s fibers. 
Oxytalan fibers, a member of the elastic system fibers, are present within PDL tissue (Beertsen 
et al., 1997). The fibers run vertically along the cementum surface of the apical root, forming a 
three-dimensional branching meshwork that surrounds the roots (Ten Cate, 2008). PDL tissue 
plays a crucial role in fixing the tooth to the alveolar bone socket through these three-
dimensional structures, which involve cushioning mechanical loads such as compressive and 
tensile forces that proceed from mastication, as well as adjusting occlusal forces depending on 
food hardness via sensory nerve perception in the PDL tissue. Thus, PDL tissue constitutes the 
bedrock of periodontium, which determines the life-span of tooth. 
Proteoglycans (PGs), including biglycan, CD44, decorin, fibromodulin, perlecan and 
versican are also present in PDL tissue as non-collagenous ECM proteins (Häkkinen et al., 
1993; Cheng et al., 1999). PGs are extracellular and cell surface-associated macromolecules 
that regulate cell adhesion, cell growth, matrix formation and bind growth factors. 
4. What causes PDL tissue loss? 
PDL tissue loss is caused mainly by the inflammatory or physical tissue destruction 
stimulated by severe periodontitis, deep caries reaching infrabony levels or irreversible 
trauma. Bacterial infection is essential for the initiation of periodontitis. One of the 
components of the cell wall of gram-negative anaerobic bacteria, lipopolysaccharide, which 
is a complex glycolipid (Lamont et al., 1998), promotes the expression of pro-inflammatory 
cytokines, such as interleukin-1 beta and tumor necrosis factor-alpha, in macrophages and 
PDL cells (Lindemann et al., 1988; Wada et al., 2004). These cytokines are reported not only 
to disturb the function of PDL cells (Quintero et al., 1995; Agarwal et al., 1998), but also to 
stimulate the production of matrix metalloproteases (MMPs), such as MMP-1, in PDL cells 
(Oyama et al., 2007; Xiang et al., 2009). MMP-1 is the major proteolytic enzyme that can 
cleave native type I and type III collagens, suggesting its aggressive contribution to the 
destruction of the PDL structure (Birkedal-Hansen, 1993). 
5. What is needed for the regeneration of PDL tissues? 
To create effective and practical therapies for the defects of PDL tissue, new approaches 
based on tissue engineering concepts have been developing. Tissue engineering, first 
described in the late 1980s, is an emerging interdisciplinary field in biomedical engineering. 
This concept aims to create or regenerate functional tissues through the use of an 
appropriate combination of three fundamental tools, namely signaling molecules, 
engineering scaffolds and cells, which together are also known as the tissue engineering 
triad (Langer & Vacanti, 1993). In addition to these triads, we think that blood supply and 
the innervation of peripheral nerves are requisites in PDL tissue regeneration. 
5.1 Signaling molecules 
Several growth factors have been reported to promote the regeneration of PDL tissue in 
vitro and in vivo. Growth factors are natural biological molecules that bind to cell-surface 
www.intechopen.com
 
Stem Cells in Clinic and Research 
 
622 
receptors and regulate key cellular activities during tissue repair, including cell 
proliferation, chemotaxis, differentiation and matrix synthesis (Chen et al., 2010a). 
5.1.1 Basic Fibroblast Growth Factor 
Basic fibroblast growth factor (bFGF) is a single-chain polypeptide mainly associated with 
mesoderm- and neuroectoderm-derived cells, and belongs to a member of the heparin-
binding growth factor family (Gospodarowicz et al., 1986). bFGF is involved in controlling 
cell proliferation, migration, differentiation and survival, and also has a role in angiogenesis 
(Savona et al., 1997). In PDL cells, bFGF has been shown to increase proliferation, the 
production of hyaluronan, heparan sulfate and osteopontin, and the expressions of MMP-1, 
MMP-3 and MMP-9 mRNA, while inhibiting the induction of ALP activity, mineralized 
nodule formation and the expressions of ALP, type I collagen, MMP-2 and tropoelastin 
mRNA (Takayama et al., 1997; Palmon et al., 2001; Shimabukuro et al., 2008; Terashima et 
al., 2008; Hakki et al., 2009). Additionally, the topical application of bFGF was shown to 
significantly induce PDL regeneration without ankylosis, root resorption and epithelial 
down-growth in an experimental alveolar bone defect model in dogs (Murakami et al., 
2003). Moreover, the regenerative effect of bFGF on PDL tissue in patients with periodontitis 
was confirmed in a randomized controlled phase II clinical trial and a multi-center 
randomized clinical trial (Kitamura et al., 2011). 
5.1.2 Transforming Growth Factor 
Transforming growth factor-β (TGF-β) consists of three 25-kDa homodimeric mammalian 
isoforms (β1, β2 and β3). TGF-β1 plays an important role in wound healing and repair 
through the induction of angiogenesis, the increase of ECM formation and the inhibition of 
inflammation and matrix degradation in mesenchymal cells (Ling & Robinson, 2002). In 
PDL cells, TGF-β1 has been reported to increase cell-surface proteoglycan genes such as 
syndecan-2 and betaglycan (Worapamorn et al., 2001), and has been reported to promote the 
synthesis of DNA, fibronectin, secreted protein acidic and rich in cytokine/osteonectin 
(SPARC), and connective tissue growth factor (CTGF) (Fujita et al., 2004; Takeuchi et al., 
2009). Previous reports have demonstrated the opposite effects of TGF-β1 on PDL cells: Si & 
Liu (2001) have shown a significant increase of ALP activity, while Brady et al. (1998) 
reported ALP suppression. Importantly, Fujii et al. (2010) reported the contrastive effects of 
TGF-β1 on primary PDL cells and a PDL stem/progenitor cell line: TGF-β1 promoted 
proliferation and showed no alternation of alpha-smooth muscle actin, type I collagen and 
fibrillin 1 mRNA expressions in primary PDL cells, whereas TGF-β1 suppressed 
proliferation and up-regulated these mRNA expressions in a PDL stem/progenitor cell line. 
These results suggest the dual effects of TGF-β1 on PDL cells depending on their 
differentiation stage. 
5.1.3 Bone Morphogenetic Protein 
Bone morphogenetic proteins (BMPs) and growth and differentiation factors (GDFs) 
together form a single family of cystine-knot cytokines in the TGF-β superfamily. A feature 
of the BMPs is their ability to induce bone formation and regulate morphogenetic activities 
in the development of various tissues. Many reports have demonstrated the promotion of 
alveolar bone and cementum regeneration by BMP-2 in several experimental periodontal 
defects (Kinoshita et al., 1997). Unfortunately, BMP-2 treatment did not induce the 
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formation of functional PDL structures, such as Sharpey's fibers, and sometimes elicited 
ankylosis (Selvig et al., 2002). Osteogenic protein-1 (OP-1/BMP-7) promoted ALP activity 
and osteocalcin expression in PDL cells (Dereka et al., 2009). Moreover, OP-1-treated PDL 
precursor cells increased proliferation (Rajshankar et al., 1998). In vivo assays with OP-1 
treatment have demonstrated the stimulation of osteogenesis, cementogenesis and new 
attachment formation in Class III furcation defects (Giannobile et al., 1998). BMP-12 has been 
reported to act as a signaling molecule during embryonic tendon, ligament and joint 
formation, and is reportedly involved in tendon and ligament healing (Wolfman et al., 1997). 
Wikesjö et al. (2004) demonstrated the promotion of new bone and cementum formation 
with BMP-12 treatment in supra-alveolar periodontal defects. Interestingly, they also 
showed that BMP-12 treatment induced to form functionally oriented PDL bridging the 
gaps between bone and cementum, whereas this was a rare observation in BMP-2 treatment. 
GDF-5, known as BMP-14, was reported to significantly induce formation of new bone, 
cementum and fibers along the root surface in one-wall intrabony defects without root 
resorption and ankylosis (Kim et al., 2009).  
5.1.4 Brain-Derived Neurotrophic Factor 
Brain-derived neurotrophic factor (BDNF) belongs to the second member of the 
neurotrophin family and is involved in differentiation, proliferation, survival, homeostasis 
and regeneration of central and peripheral neurons by binding to cell surface receptors TrkB 
and p75NTR (Ebendal, 1992). PDL cells have been reported to increase proliferation and the 
expressions of ALP and osteocalcin mRNA and osteopontin, BMP-2 and type I collagen 
synthesis through BDNF exposure (Tsuboi et al., 2001). Moreover, BDNF or BDNF/high-
molecular-weight-hyaluronic acid reportedly increased the formation of new alveolar bone, 
cementum, Sharpey's fiber-like connective tissues and blood capillary in Class III furcation 
defects in a dog model (Takeda et al., 2005; Takeda et al., 2011). 
5.1.5 Connective Tissue Growth Factor 
Connective tissue growth factor (CTGF) is a cysteine-rich, matrix-associated, and heparin-
binding protein that was originally discovered as a chemotactic and mitogenic factor for 
fibroblast-like cells in vitro (Bradham et al., 1991). After CTGF treatment, hMSCs revealed a 
typical fibroblastic phenotype and failed to show osteogenic or chondrogenic differentiation 
(Lee et al., 2006). CTGF stimulated proliferation, ALP, type I collagen, and periostin mRNA 
expression, ALP activity and collagen synthesis in PDL cells, while CTGF induced little 
change of osteopontin and osteocalcin mRNA expressions (Asano et al., 2005). 
Transplantation of CTGF-treated PDL progenitors exhibited an increase of type III collagen, 
biglycan and periostin mRNA expressions and enhanced the formation of PDL-like tissue, 
namely dense collagen fiber bundles with a high expression level of periostin in a mouse 
model (Dangaria et al., 2009).  
5.1.6 Wnt 
Wnts are a family of 19 secreted cysteine-rich glycoproteins that participate in embryonic 
development and adult homeostasis by regulating cellular proliferation, differentiation and 
apoptosis (Logan & Nusse, 2004). Wnt proteins transduce multiple signaling cascades 
including the canonical Wnt/β-catenin pathway, the Wnt/Ca2+ pathway and the 
Wnt/polarity pathway. Among those, canonical Wnt/β-catenin has been reported to 
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increase bone formation through the stimulation of osteoblast development and the 
inhibition of osteoblast and osteocyte apoptosis (Kato et al., 2002; Bodine et al., 2004). The 
canonical Wnt/β-catenin pathway has been shown to promote mineralized nodule 
formation, ALP activity and osteogenic transcription factor expression in PDL cells (Heo et 
al., 2010), while the pathway reportedly suppressed ALP activity and cementum function-
associated gene expression in cementoblasts (Sodek & Limeback, 1979). 
5.1.7 Platelet-Derived Growth Factor 
Platelet-derived growth factor (PDGF) is composed of two disulfide bounded polypeptide 
chains that are encoded by two different genes, PDGF-A and PDGF-B. In nature, PDGF can 
exist as a homodimer: PDGF-AA and PDGF-BB. PDGF-BB was reported to promote the 
proliferation, adhesion, type I collagen synthesis and migration of PDL cells (Belal et al., 
2006), as well as to enhance periodontal regeneration of Class III furcation defects in beagle 
dogs without significant ankylosis or root resorption (Cho et al., 1995). Moreover, PDGF-BB 
has been shown to stimulate a significant increase in the rate of clinical attachment level 
gain and bone defect fill, as well as to reduce gingival recession (Nevins et al., 2005). 
5.1.8 Enamel Matrix Derivative 
Porcine enamel matrix protein was reported to induce new bone and cementum formation 
in periodontal defects in monkeys (Hammarstrom, 1997). Since then, many in vivo and in 
vitro studies, as well as clinical trials, have revealed the progression of PDL regeneration in 
the use of enamel matrix derivative (EMD). EMD has been shown to promote the growth, 
proliferation, migration, adhesion and protein synthesis of PDL fibroblasts, osteoblasts and 
cementoblasts, as well as to regulate their bone-related gene expressions (Carinci et al., 
2006). Additionally, EMD has been shown to induce the production of several growth 
factors in PDL cells and osteoblasts (Mizutani et al., 2003; Heng et al., 2007). 
5.2 Scaffolds 
Scaffolds that have the capabilities of growth factor delivery, easy cellular infiltration and 
subsequent tissue integration become powerful tools for tissue engineering. PDL cells are 
subjected to a multitude of factors and microenvironments presented by local substrates and 
their surface conditions. There are two classes of scaffold biomaterials: natural materials and 
synthetic materials.  
Of the natural materials, collagens are ubiquitous interstitial proteins responsible for 
maintaining structural integrity and are rapidly synthesized and degraded in PDL tissue 
(Sodek & Limeback, 1979). Several reports have revealed the promotion of PDL regeneration 
using collagen gels incorporating BMP-2, as well as gelatin hydrogels containing bFGF 
(King et al., 1998; Nakahara et al., 2003).  
Chitosan is a deacetylated derivative of chitin, the second most abundant natural polymer 
found in the shells of crustaceans (Kim et al., 2008). Chitosan has been shown to increase 
type I collagen and ALP mRNA expressions in PDL cells, and chitosan scaffolds have been 
reported to induce the formation of new bone and cementum in one-wall intrabony defects 
(Yeo et al., 2005; Pang et al., 2005). Additionally, chitosan scaffolds that release growth 
factors such as PDGF or bFGF have been shown to accelerate PDL regeneration (Inanç et al., 
2007; Akman et al., 2010). 
Calcium hydroxyapatite is a main component of root cementum and alveolar bone. PDL 
cells cultured with nanoparticles of hydroxyapatite have been reported to significantly 
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increase proliferation and ALP activity (Sun et al., 2007), and porous hydroxyapatite 
scaffolds have induced pocket depth reduction and attachment gain in PDL tissue (Carraro, 
1988). Moreover, numerous hybrid calcium hydroxyapatite scaffolds, including 
nanohydroxyapatite/chitosan (Zhang et al., 2007), nanohydroxyapatite/collagen (Fukui et 
al., 2008) and hydroxyapatite/gelatin components (Rungsiyanont et al., 2011) have shown 
promise for PDL tissue regeneration. GEM 21S®, which consists of a combination of PDGF-
BB and β-tricalcium phosphate (TCP) matrix ranging in size from 250 to 1000 μm ("small β-
TCP"), has been used widely in the treatment of periodontitis. 
Synthetic polymers have also been used as scaffold materials for tissue engineering. In 
particular, polyesters such as polyglycolic acid (PGA), polylactic acid (PLA) and 
polylacticcoglycolic acid (PLGA) have been frequently used for PDL regeneration (Chen et 
al., 2010b). Moreover, several reports have demonstrated the utility of the combination of 
growth factors and synthetic polymers such as GDF-5/PLGA (Kwon et al., 2010). 
Interestingly, Chen et al. revealed that BMP-2-loaded pellets incorporated into glycidyl 
methacrylated dextran/gelatin scaffolds stimulated not only bone and cementum formation, 
but also PDL-like connective tissue regeneration (Chen et al., 2007). Implantation of TGF-β3 
in lyophilized Matrigel® scaffolds in baboon Class III furcation defects with minced 
fragments of rectus abdominis muscle reportedly induced responding stem cells to 
stimulate the formation of large amounts of alveolar bone with associated PDL fibers and 
newly formed cementum (Ripamonti et al., 2009). 
5.3 Cells 
The use of stem cells as primary cell sources is of enormous interest to clinicians and 
researchers for their great potential in tissue engineering applications. Sources of stem cells 
from human (Feng et al., 2010) and swine (Ding et al., 2010) PDL tissues are reported to be 
the most potent for PDL tissue regeneration, as well as canine (Kawaguchi et al., 2004) and 
human (Yamada et al., 2006) bone marrow and rat adipose-tissue (Tobita et al., 2008). Recent 
studies have attempted topical applications of stem cells combined with growth factors 
and/or scaffolds for PDL tissue regeneration. Indeed, the combination of platelet-rich 
plasma with growth factors, fibrin scaffolds and BMMSCs successfully regenerated PDL 
tissue in a clinical setting (Yamada et al., 2006). Adipose-derived stem cells mixed with 
platelet-rich plasma promoted PDL regeneration in rat PDL tissue defects (Tobita et al., 
2008). Moreover, the PDL cell population has been described to include stem/progenitor 
cells that have the possibility to repair destructed PDL tissues by recruiting their latent 
regenerative potential to differentiate into fibroblasts, osteoblasts or cementoblasts in 
response to their microenvironment (Melcher, 1976; McCulloch et al., 1987). Bovine derived 
bone substitute scaffolds mixed with fibrin were shown to represent high biological affinity 
and support for the growth, migration and differentiation of PDL stem cells (Trubiani et al., 
2008). Collagen scaffolds were shown to stimulate PDL stem/progenitor cells to attach, 
proliferate, exhibit a PDL spindle-like morphology and subsequently form PDL-like tissue 
(Luan et al., 2009). BMP-2 stimulation was shown to induce mineralized nodule formation of 
multipotent PDL cells, while bFGF stimulation elicited capillary-like structure formations 
(Shirai et al., 2009). Hydroxyapatite/tricalcium phosphate blocks, into which stem cells from 
root apical papilla were loaded, when furthermore coated with Gelfoam containing PDL 
stem cells and implanted into extracted sockets, developed PDL-like tissue around the 
blocks (Sonoyama et al., 2006). These results suggest the efficacy of therapeutic approaches 
based on tissue engineering triads in PDL tissue regeneration. 
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5.4 Blood supply 
PDL tissues are nourished from supraperiosteal arterioles along the surface of alveolar bone, 
vessels of the PDL region and arterioles from the interdental septum extending into the 
gingival and sulcus area (Egelberg, 1967). Therefore, the lack of sufficient blood supply may 
restrict PDL regeneration. bFGF is a potent mediator for angiogenesis and plays an essential 
role in the formation of new blood vessels, including the differentiation of angioblasts and 
the subsequent formation of vascular tubules (Savona et al., 1997). Moreover, a recent report 
showed that tissue engineered PDL constructs incorporating human umbilical vein 
endothelial cells in vitro induced the formation of capillary-like structures, ALP activity and 
collagen deposition within the constructs (Nagai et al., 2009) 
5.5 Innervation of peripheral nerves 
Diverse functions of the nervous system have been reported in peripheral tissues. Peripheral 
nerves regulate DNA synthesis and proliferation of abdominal cells (Kiba et al., 1996). 
Denervation has been shown to suppress osteoclast activities in vertebral and mandibular 
bone (Imai & Matsusue, 2002). Furthermore, alveolar nerve denervation leads to a reduction 
in the distribution of epithelial cell rests of Malassez (Yamashiro et al., 2000), resulting in a 
narrowing of the PDL width and dento-alveolar ankylosis (Fujiyama et al., 2004). 
Neuropeptides, such as substance P and calcitonin gene-related peptides that are released 
from axons of sensory neurons in PDL tissue (Jacobsen et al., 1998), have been shown to 
stimulate angiogenesis, bone remodeling (Hukkanen et al., 1993), fibroblast proliferation 
and collagen organization (Burssens et al., 2005). Therefore, the peripheral nervous system 
also plays important roles in homeostasis and the regeneration of PDL tissue. 
6. Characteristics of PDL stem cells 
A “stem cell” is capable of self-renewal and multi-lineage differentiation. In other words, 
stem cells possess the potential to propagate and generate additional stem cells, and can 
differentiate and commit to maturation along multiple lineages that produce a range of 
specialized cell types. Human mesenchymal stem cells (MSCs) were originally isolated in 
aspirates of adult bone marrow by their capacity to form clonogenic clusters of adherent 
fibroblast colony-forming units (Friedenstein et al., 1974). Additionally, they displayed the 
potential to undergo extensive proliferation and to differentiate into mesodermal lineage 
cells, such as adipocytes, chondrocytes and osteoblasts, both in vitro and after transfer in 
vivo (Pittenger et al., 1999). Human MSCs are also reported to exhibit endodermic and 
neuroectodermic differentiation potentials (Castro-Malaspina et al., 1980; Petersen et al., 
1999; Kopen et al., 1999; Gronthos & Simmons, 1995). In recent years, MSCs have been 
identified in various tissues throughout the human adult body including bone marrow, 
adipose tissue, placenta and muscle (Baroffio et al., 1996; Fukuchi et al., 2004; Pittenger et al., 
1999; Zannettino et al., 2008). 
It is considered that PDL tissue also harbors a small number of MSCs in niches that may be 
derived from DF cells, responsible for maintaining and regenerating periodontal tissue 
structure and function. The MSC population in PDL tissue has the potential to differentiate 
into fibroblasts, osteoblasts, and cementoblasts, which are critical cell populations to 
maintain and remodel periodontal tissue. In 2004, a multipotent PDL stem cell population, 
termed as PDLSC, was first isolated from the PDL tissue of extracted human third molar 
teeth (Seo et al., 2004). PDLSCs represent typical properties of MSCs, as well as unique 
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properties. PDLSCs exhibit the self-renewing capacity to generate clonogenic adherent cell 
colonies to tissue culture plastic and resemble fibroblasts in their spindle-like shapes in 
vitro. Several studies have reported that PDLSCs express cell surface markers, such as 
STRO-1 (putative stem cell marker), CD146 (perivascular cell marker), STRO-3 (tissue 
nonspecific ALP), CD13, CD29 (integrin β-1), CD44, CD90 (Thy-1), CD105 (endoglin), CD106 
(VCAM-1), and CD166 (ALCAM) (Nagatomo et al., 2006; Seo et al., 2004; Trubiani et al., 
2005; Wada et al., 2009), similar to BMMSCs (Shi & Gronthos 2003; Gronthos et al., 2007), as 
well as embryonic markers, including OCT-4, SSEA-1 and SSEA-4 (Trubiani et al., 2010). 
PDLSCs have so far been isolated from PDL heterogeneous cell populations using STRO-1 
and CD146 antibodies (Seo et al., 2004), although the percentage of STRO-1-positive cells in 
the PDL tissue is reportedly not to be very high (STRO-1 positive cells: 1.2-7.68%) 
(Nagatomo et al., 2006; Xu et al., 2009). Additionally, PDLSCs express a PDL marker, 
scleraxis, suggesting that PDLSCs may belong to a unique population of MSCs. 
PDLSCs also possess the multipotential to differentiate in vitro into various types of cells, 
such as osteoblasts, adipocytes and chondrocytes, similar to BMMSCs (Gay et al., 2007). In 
addition to a common multipotency with BMMSCs, PDLSCs represent a unique potential to 
form cementum and PDL-like tissues including Sharpey's fiber-like structure in vivo, when 
subcutaneously transplanted into the dorsal surfaces of immunocompromised mice with a 
hydroxyapatite or β-TCP carrier (Seo et al., 2004). Furthermore, human PDLSCs that were 
transplanted into surgically created defects at the periodontal area of mandibular molars in 
immunocompromised rats were integrated into the PDL tissue, resulting in homing on the 
surfaces of alveolar bone and tooth root (Seo, et al., 2004). Swine or canine PDLSCs have also 
been reported to regenerate PDL tissues when transplanted into surgically created 
periodontal defect areas in swine or canine models (Liu et al., 2008; Park et al., 2010). 
Immunomodulatory property is also known to be one of the characteristics of MSCs 
(Bartholomew et al., 2002). MSCs have been found to inhibit mixed lymphocyte reactions 
(MLR) and T-lymphocyte proliferation following mitogenic stimulation in vitro, despite 
expression of leucocyte antigen (HLA) major histocompatibility complex (MHC) 
(Bartholomew et al., 2002; Di Nicola et al., 2002), suggesting allogeneic BMMSC 
administration may be an appropriate stem cell therapy technique. Similarly, human and 
canine PDLSCs have been reported to possess the capacity to suppress immune responses 
and inflammatory reactions (Kim et al., 2010; Wada et al., 2009). It has been demonstrated 
that human PDLSCs inhibited peripheral blood mononuclear cell proliferation stimulated 
with mitogen or in MLR, and this inhibition was mediated by soluble factors including TGF-
β1, hepatocyte growth factor (HGF) and indoleamine 2, 3-dioxygenase (IDO), known to be 
induced by interferon-gamma (IFN-γ) (Wada et al., 2009). In a swine model with 
experimental periodontal bone defects, the transplantation of a sheet of allogenic PDLSCs 
reversed the periodontitis through the low immunogenicity and immunosuppressive 
function possessed by PDLSCs (Ding et al., 2010). 
In the first human trial report using ex-vivo-expanded primary PDL cells including PDLSCs, 
the cells were mixed with bone grafting material and transplanted into the intrabony defects 
of deep periodontal pockets of three patients. The results of the transplantations showed a 
significant improvement of periodontal diseases, suggesting that PDLSC transplantation 
could be a safe and promising treatment for clinical periodontitis (Feng et al., 2010). 
Furthermore, it has been reported that human PDLSCs recovered from cryopreserved 
human PDL tissue maintained normal PDLSC characteristics, including expression of 
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STRO-1, single-colony-strain generation, multipotency and cementum/PDL-like tissue 
generation, providing a possible and practical clinical approach for the utilization of 
PDLSCs isolated from frozen PDL tissues (Seo et al., 2005). 
These findings demonstrate that PDLSCs not only possess stem cell characteristics, 
including self-renewal, multipotency and immunomodulatory properties similar to 
BMMSCs, but also hold a unique potential to fabricate three-dimensional PDL tissue. 
7. PDL stem cell lines 
Because there are a small number of stem cells in PDL tissues, researchers have tried to 
establish immortalized PDL stem cell lines for the convenience and consistency of analyses. 
Several genes, such as SV 40 large T-antigen, human telomerase transcriptase, human 
papillomavirus 16-related E6E7, Bmi-1 and BMP4, have been transduced into mammalian 
PDL cells. As a consequence, clonal PDL cell lines derived from mice (Saito et al., 2002), 
swine (Ibi et al., 2007) and humans (Kamata et al., 2004; Fujita et al., 2005; Pi et al., 2007; Mi 
et al., 2011) have been developed. In addition, clonal cell lines from mouse dental follicle 
(DF) cells as a source of PDLSCs have also been reported (Saito et al., 2005; Luan et al., 2006). 
However, the multipotency in these cell lines has not been analyzed in detail. One group 
reported that the clonal swine PDL cell lines exhibited osteoblastic differentiation and the 
formation of tube-like structures (Shirai et al., 2009). Recently, our group succeeded in 
establishing two clonal human PDL cell lines with multipotency by transducing primary 
PDL cells with both SV 40 large T-antigen and human telomerase reverse transcriptase 
genes (Fujii et al., 2006; Fujii et al., 2008; Tomokiyo et al., 2008). These clonal cell lines had 
unique characteristics: Cell line 1-11 demonstrated osteoblastic and adipocytic 
differentiation (Fig. 1) (Fujii et al., 2008), and cell line 1-17 could differentiate into 
osteoblasts, chondrocytes, adipocytes and neurocytes (Fig. 2) (Tomokiyo et al., 2008).  
 
 
 
 
 
Fig. 1. Osteoblastic (a) and adiopocytic (b) differentiation of cell line 1-11. Cell line 1–11 was 
cultured for 4 weeks in osteoblastic induction medium. von Kossa-positive deposits (dark 
brown dots) were observed in (a). (b): Cell line 1–11 was cultured for 18 days in adipocytic 
induction medium. Oil red O-positive clusters (red) were observed. Bars: 150 μm. 
Flow cytometric analysis demonstrated that the percentage of cells expressing CD13, CD29, 
CD44, CD71, CD90, CD105, and CD166 was very high in both cell lines, while the number of 
cells expressing an endothelial marker, CD18 and a hematopoietic marker, CD34 was low 
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(data shown partially in Fig. 3). Lindroos et al. (2008) also reported the expressions of CD13, 
CD 29, CD44, CD90, CD105, and CD166 in human PDLSCs. Cell line 1-11 expressed other 
MSC markers, STRO-1 and CD146/MUC18, whereas cell line 1-17 contained STRO-1 only 
(data not shown), although these markers are also believed to be expressed in human and 
mouse PDLSCs (Seo et al., 2004; Xu et al., 2009). 
On the other hand, cell line 1-17 intensely expressed ES cell marker genes, OCT-4 and 
Nanog, whereas cell line 1-11 expressed these markers weakly (Fig. 4). However, these 
expressions were reduced when the cells were cultured in osteoblast induction medium 
(data not shown). Furthermore, both cell lines expressed neural crest (NC)-related genes, 
Nestin, p75NTR and Slug at almost equivalent levels. Based on these results, these cell lines 
were exactly derived from NC, and cell line 1-17 may be more immature than cell line 1-11. 
 
 
 
 
 
 
 
 
Fig. 2. Osteoblastic (a), adipocytic (b), chondrocytic (c), and neurocytic (d) differentiation of 
cell line 1–17. (a): Cell line 1–17 was cultured for 4 weeks in osteoblastic induction medium 
and then subjected to von Kossa staining. The von Kossa-positive calcified deposits (dark 
brown dots) were detected. (b): Cell line 1–17 was cultured for 18 days in adipocytic 
induction medium. Oil red O-positive clusters (red) were observed. (c): Cell line 1-17 was 
cultured for 4 weeks in chondrocytic induction medium and then subjected to Alcian blue 
staining. (d): Cell line 1-17 was cultured for 4 weeks in neurocytic induction medium and 
then subjected to immunocytochemical staining of human neurofilament (green). The 
extension of dendrite-like processes (arrows) was observed. Bars: 150 μm. 
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Fig. 3. Flow cytometric analysis of cell line 1-11 with antibodies reactive to the stem cell-
related surface molecules CD29, CD44, CD71 and CD105, and the endothelial and 
hematopoietic surface molecules, CD18 and CD34, respectively. 
 
 
Fig. 4. Semi-quantitative RT-PCR analysis shows transcription levels of the ES cell-related 
pluripotency genes, OCT-4 and Nanog (a), and CNC-related genes, Nestin, p75NTR and 
Slug (b), in cell lines 1-11 and 1–17. 
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In addition, both cell lines expressed PDL phenotype-related genes, periostin and scleraxis 
(Yokoi et al., 2007), at almost equivalent levels while human MSCs showed little expression 
of the respective genes (Fig. 5a). Immunofluorescent data demonstrated the higher 
expression of periostin in cell line 1-17 compared with hMSCs (Fig. 5b). These data indicate 
that the cell lines are obviously PDL-committed cells, exhibiting the phenotypes of stem 
cells. 
 
 
Fig. 5. Semi-quantitative RT-PCR analysis concerning the transcription of the PDL-related 
genes, periostin and scleraxis in cell lines 1-11 and 1-17 and in hMSCs (a). 
Immunocytochemical analysis of the expression of periostin in cell line 1-17 and MSCs (b). 
When cell line 1-11 was subcutaneously transplanted with β-TCP into the dorsal side of 
immunodeficient mice for 8 weeks, the cells fabricated PDL-like tissue including Sharpey’s 
fiber-like structures (Fig. 6a), while cell line 1-17 did not exhibit such potential (data not 
shown). Furthermore, when transplanted into periodontal defects formed in 
immunodeficient rats for 3 weeks, cell line 1-11 homed on the surfaces of bone and root and 
between bone and root, namely within the ligament tissue, while cell line 1-17 was localized 
only within the ligament tissue (Fig. 6b, c). These observations were very similar to a 
previous report by Seo, et al. (2004). 
 
 
 
 
 
Fig.6. Trichrome staining of cell line 1-11 transplanted with β-TCP (*) into immunodeficient 
mice for 8 weeks (a). Sharpey’s fiber-like structures were observed (arrows). 
Immunolocalization of anti-human mitochondria-positive cells after transplantation of cell 
lines 1-11 (b) or 1-17 (c) into periodontal defects in immunodeficient rats. Immuno-positive 
cells were detected on the surface of bone (red arrows) and tooth root (black arrows) and 
within ligament tissue (yellow arrows). Bars: 50 μm. 
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The treatment of two cell lines by bFGF provided intriguing results concerning osteoblastic 
differentiation. Although both cell lines cultured in osteoblastic differentiation medium 
produced calcified deposits at almost equivalent volumes, bFGF provoked these 
productions in cell line 1-11, while inhibited the productions in cell line 1-17 almost 
completely (Fig. 7). 
 
 
Fig. 7. von Kossa staining of cell lines 1-11 (a, b) and 1-17 (c, d) treated with (b, d) or without 
(a, c) bFGF in osteoblastic differentiation medium. Dark brown dots show von Kossa-
positive calcified deposits. Bar: 200 μm. 
Thus, our results indicate that both cell lines met the prerequisite for PDL stem cells, and 
furthermore, that the differentiation stage of cell line 1-17 may be lower than that of cell line 
1-11, based on the differences of multipotency and phenotypes between the lines and the 
transplantation analyses. These differences may be related to the expression of CD146 or the 
responsiveness to bFGF. Therefore, we believe that there may be distinguishing factors in 
these cell lines that influence the direction of stem cell differentiation within the PDL tissues. 
8. Conclusions and future directions 
Both cell lines exhibited characteristics of PDLSCs and permitted the routine analyses 
associated with PDLSCs. Their phenotypes, however, were somewhat different from each 
other. We believe that PDLSCs originate from DF cells, which stay in a niche in the PDL 
tissue during and after its development, and that our established cell lines would signify the 
existence of stem cells at various differentiation stages in the PDL tissue (Fig. 8). A 
differential analysis between these two clones will allow us to further reveal the mechanism 
of PDLSC differentiation. These results will enable elucidation of signals that direct stem 
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cells including MSCs, iPS cells or ES cells toward PDL-lineage cells, as well as to identify the 
optimum signaling molecules and scaffolds for PDL regeneration. With the integration of 
these elements, the potential development of an efficient therapy for PDL regeneration is 
likely. 
 
 
Fig. 8. Schema explaining the differentiation stages of undifferentiated cells included in the 
PDL tissue. 
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